Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: A case report

BACKGROUND: Immune checkpoint inhibitors have significantly improved survivals for an increasing range of malignancies but at the cost of several immune-related adverse events, the management of which can be challenging due to its mimicry of other autoimmune related disorders such as immunoglobulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Rohit, Guzman, Grace, Karimi, Saman, Giulianotti, Pier Cristoforo, Lora, Alfredo Jose Mena, Jain, Shikha, Khan, Meshaal, Boulay, Brian R, Chen, Yolande
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297397/
https://www.ncbi.nlm.nih.gov/pubmed/36051149
http://dx.doi.org/10.12998/wjcc.v10.i20.7124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297397/
https://www.ncbi.nlm.nih.gov/pubmed/36051149
http://dx.doi.org/10.12998/wjcc.v10.i20.7124

Ejemplares similares